Value Bridge — MARSHFIELD MEDICAL CENTER
Current $-100M → Target $-83M (+$16.9M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-99.7M
Current EBITDA
$-82.8M
Target EBITDA
+$16.9M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$3.8M
Payer Mix Optimization
$9.2M
Cost to Collect Reduction
$3.1M
Clean Claim Improvement
$2.3M
Volume & Rate Growth
$15.3M
What This Means
The 7-lever model projects a 0% EBITDA uplift from $-100M to $-83M. The highest-impact lever is Volume & Rate Growth at $6.1M probability-weighted.
IC talking point: "We see $17M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $186M in equity value creation."